In search of Alzheimer’s disease treatment methods: trends of clinical trials
There is a strong necessity to develop new treatments for Alzheimer’s disease (AD) as its frequency is rapidly growing with the ageing population. There were 25 pharmacological agents involved in phase I trials, 52 in phase II, and 28 agents in phase III clinical trials in 2017. More than two third...
Saved in:
Main Authors: | G. Pakulaitė, V. Regelskytė, E. Audronytė, J. Kuzmickienė, G. Kaubrys |
---|---|
Format: | Article |
Language: | English |
Published: |
Vilnius University Press
2018-03-01
|
Series: | Neurologijos seminarai |
Subjects: | |
Online Access: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/27849 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease
by: Tapas K. Sur, et al.
Published: (2025-06-01) -
Diagnosis and Treatment of Alzheimer’s Disease: Current Update
by: Younghee Yim, et al.
Published: (2025-01-01) -
Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy
by: Eun Hee Ahn, et al.
Published: (2025-01-01) -
Natural bioactive compounds form herbal medicine in Alzheimer’s disease: from the perspective of GSK-3β
by: Mei Wang, et al.
Published: (2025-02-01) -
Comparative the efficacy and safety of Gosuranemab, Semorinemab, Tilavonemab, and Zagotenemab in patients with Alzheimer’s disease: a systematic review and network meta-analysis of randomized controlled trials
by: Wenting Cai, et al.
Published: (2025-01-01)